1. Home
  2. BOLD vs AMPG Comparison

BOLD vs AMPG Comparison

Compare BOLD & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • AMPG
  • Stock Information
  • Founded
  • BOLD 2018
  • AMPG 2002
  • Country
  • BOLD United States
  • AMPG United States
  • Employees
  • BOLD N/A
  • AMPG N/A
  • Industry
  • BOLD
  • AMPG Telecommunications Equipment
  • Sector
  • BOLD
  • AMPG Telecommunications
  • Exchange
  • BOLD Nasdaq
  • AMPG Nasdaq
  • Market Cap
  • BOLD 30.3M
  • AMPG 34.2M
  • IPO Year
  • BOLD 2024
  • AMPG N/A
  • Fundamental
  • Price
  • BOLD $1.44
  • AMPG $1.85
  • Analyst Decision
  • BOLD Hold
  • AMPG Strong Buy
  • Analyst Count
  • BOLD 1
  • AMPG 1
  • Target Price
  • BOLD N/A
  • AMPG $5.00
  • AVG Volume (30 Days)
  • BOLD 61.2K
  • AMPG 325.4K
  • Earning Date
  • BOLD 05-09-2025
  • AMPG 05-27-2025
  • Dividend Yield
  • BOLD N/A
  • AMPG N/A
  • EPS Growth
  • BOLD N/A
  • AMPG N/A
  • EPS
  • BOLD N/A
  • AMPG N/A
  • Revenue
  • BOLD N/A
  • AMPG $9,508,372.00
  • Revenue This Year
  • BOLD N/A
  • AMPG $82.37
  • Revenue Next Year
  • BOLD N/A
  • AMPG $76.47
  • P/E Ratio
  • BOLD N/A
  • AMPG N/A
  • Revenue Growth
  • BOLD N/A
  • AMPG N/A
  • 52 Week Low
  • BOLD $1.06
  • AMPG $0.64
  • 52 Week High
  • BOLD $12.26
  • AMPG $6.43
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • AMPG 56.16
  • Support Level
  • BOLD N/A
  • AMPG $1.70
  • Resistance Level
  • BOLD N/A
  • AMPG $1.94
  • Average True Range (ATR)
  • BOLD 0.00
  • AMPG 0.16
  • MACD
  • BOLD 0.00
  • AMPG 0.01
  • Stochastic Oscillator
  • BOLD 0.00
  • AMPG 75.00

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

Share on Social Networks: